TSI Health Sciences Expands European Presence, Opens Its First UK Office

Adrian Lindridge Named European Sales Director

MISSOULA, Mont. (June 14, 2006) – TSI Health Sciences, a leading developer, producer and marketer of nutraceutical and pharmaceutical ingredients, today announced the opening of its first sales and marketing office in Europe. Adrian Lindridge has been appointed sales director, Europe, and will be based out of the new office in Rochdale, Lancashire, UK.

“Demand for high quality nutraceutical ingredients in Europe has steadily increased over the past few years,” said Larry Kolb, TSI Health Sciences president, U.S. operations. “TSI has established a presence in this market and we’ve realized we needed an office in Europe to build upon our momentum. This office will allow us to better serve our existing clients and increase our customer base.”

Lindridge will be responsible for creating and implementing comprehensive sales and marketing strategies to educate European customers on the company and its extensive product lines. Prior to joining TSI, Lindridge worked for SSL International plc, a global consumer healthcare company. During his 18 years of employment with SSL, Lindridge held many positions, including head of the OTC business development, director of UK consumer marketing and marketing manager, Europe. Lindridge has an MBA from University of Bradford and a bachelor’s degree in physiology from University of Leeds.

About TSI Health Sciences
TSI Health Sciences, www.tsiinc.com, has evolved throughout the last decade to focus primarily on in-house, high-end ingredient production and has become a leading developer, producer and marketer of nutraceutical ingredients to the dietary supplement, pharmaceutical and food and beverage industries. With US operations based in Missoula, Mont., TSI was founded in 1996 and has offices worldwide, including a 60-acre, fully integrated manufacturing, research, quality assurance and quality control campus in Jiangyin, China. The company’s comprehensive product range includes botanical, marine and natural product extracts, as well as synthesized compounds. TSI guarantees full-service cGMP manufacturing through TSI Manufacturing Systems, with divisions specializing in small and large-scale botanical and natural product extraction, large-scale chemical synthesis production and secondary processing capabilities.

# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.